These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 24345725

  • 1. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
    Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.
    Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
    [Abstract] [Full Text] [Related]

  • 2. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N, Karnes RJ, Cozzarini C, Fiorino C, Gandaglia G, Joniau S, Boorjian SA, Goldner G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T, Briganti A.
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [Abstract] [Full Text] [Related]

  • 3. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N, Karnes RJ, Boorjian SA, Moschini M, Morlacco A, Bossi A, Seisen T, Cozzarini C, Fiorino C, Noris Chiorda B, Gandaglia G, Dell'Oglio P, Joniau S, Tosco L, Shariat S, Goldner G, Hinkelbein W, Bartkowiak D, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A.
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [Abstract] [Full Text] [Related]

  • 4. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
    Briganti A, Wiegel T, Joniau S, Cozzarini C, Bianchi M, Sun M, Tombal B, Haustermans K, Budiharto T, Hinkelbein W, Di Muzio N, Karakiewicz PI, Montorsi F, Van Poppel H.
    Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
    [Abstract] [Full Text] [Related]

  • 5. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G, Ploussard G, Valerio M, Marra G, Moschini M, Martini A, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Afferi L, Rakauskas A, Gontero P, Mattei A, Montorsi F, Briganti A.
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [Abstract] [Full Text] [Related]

  • 7. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.
    Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
    [Abstract] [Full Text] [Related]

  • 8. Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy.
    Mir MC, Li J, Klink JC, Kattan MW, Klein EA, Stephenson AJ.
    Eur Urol; 2014 Aug; 66(2):204-10. PubMed ID: 24007712
    [Abstract] [Full Text] [Related]

  • 9. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
    Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ.
    Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
    [Abstract] [Full Text] [Related]

  • 10. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F, Sood A, Sammon JD, Hsu L, Beyer B, Moschini M, Gandaglia G, Rogers CG, Haese A, Montorsi F, Graefen M, Briganti A, Menon M.
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [Abstract] [Full Text] [Related]

  • 11. Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.
    Campbell SR, Tom MC, Agrawal S, Efstathiou JA, Michalski JM, Abramowitz MC, Pollack A, Spratt DE, Hearn JWD, Stephans KL, Gao T, Li J, Tendulkar RD.
    Eur Urol Oncol; 2022 Jun; 5(3):304-313. PubMed ID: 34016556
    [Abstract] [Full Text] [Related]

  • 12. Predicting survival of men with recurrent prostate cancer after radical prostatectomy.
    Dell'Oglio P, Suardi N, Boorjian SA, Fossati N, Gandaglia G, Tian Z, Moschini M, Capitanio U, Karakiewicz PI, Montorsi F, Karnes RJ, Briganti A.
    Eur J Cancer; 2016 Feb; 54():27-34. PubMed ID: 26707594
    [Abstract] [Full Text] [Related]

  • 13. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
    Briganti A, Joniau S, Gandaglia G, Cozzarini C, Sun M, Tombal B, Haustermans K, Hinkelbein W, Shariat SF, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):960-7. PubMed ID: 24351411
    [Abstract] [Full Text] [Related]

  • 14. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
    Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ.
    Eur Urol; 2015 Feb 01; 67(2):204-9. PubMed ID: 25294696
    [Abstract] [Full Text] [Related]

  • 15. Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification.
    Abdollah F, Boorjian S, Cozzarini C, Suardi N, Sun M, Fiorino C, di Muzio N, Karakiewicz PI, Montorsi F, Karnes RJ, Briganti A.
    Eur Urol; 2013 Oct 01; 64(4):557-64. PubMed ID: 23506833
    [Abstract] [Full Text] [Related]

  • 16. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
    Viani GA, Hamamura AC, Correa AC, de Arruda FT.
    Int Braz J Urol; 2019 Oct 01; 45(2):237-245. PubMed ID: 30676298
    [Abstract] [Full Text] [Related]

  • 17. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.
    Eur Urol; 2016 Jun 01; 69(6):1142-8. PubMed ID: 26749093
    [Abstract] [Full Text] [Related]

  • 18. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
    Abdollah F, Klett DE, Sood A, Sammon JD, Pucheril D, Dalela D, Diaz M, Peabody JO, Trinh QD, Menon M.
    BJU Int; 2015 Nov 01; 116(5):703-12. PubMed ID: 25413443
    [Abstract] [Full Text] [Related]

  • 19. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun 01; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 20. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.
    Nini A, Gandaglia G, Fossati N, Suardi N, Cucchiara V, Dell'Oglio P, Cazzaniga W, Luzzago S, Montorsi F, Briganti A.
    Eur Urol; 2015 Nov 01; 68(5):777-84. PubMed ID: 25959166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.